Should I buy or sell IMV stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IMV in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IMV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMV, but not buy additional shares or sell existing shares. View IMV analyst ratings or view top-rated stocks .

When did IMV's stock split?

IMV's stock reverse split before market open on Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of IMV own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMV investors own include Aurora Cannabis (ACB) , 10094 (IRD.TO) (IRD) , Village Farms International (VFF) , Bombardier, Inc. Class B (BBD.B) , Cronos Group (MJN) , Aphria (APHA) , Enbridge (ENB) , Sorrento Therapeutics (SRNE) , Medical Facilities (DR) and ReNeuron Group (RENE) .

How do I buy shares of IMV?

Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:IMV

IMV (IMV) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free IMV Stock Alerts

Compare

Today's Range: N/A
50-Day Range: C$1.12
▼
C$1.12
52-Week Range: N/A

Volume: 15,761 shs
Average Volume: 56,822 shs
Market Capitalization: C$13.12 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Headlines

Get IMV alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About IMV Stock (TSE:IMV)

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

IMV Stock News Headlines

April 17, 2024 | finance.yahoo.com

Maveropepimut-S (MVP-S, previously known as DPX-Survivac) Drug Research Report 2024: 7 Major Markets Size, Forecasts, and Emerging Insights 2019-2032

April 13, 2024 | msn.com

‘Golden Bachelor’ pair announces divorce after three months of marriage

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 12, 2024 | msn.com

Toyota Mini Fortuner News: Price, launch date, engine, specifications — All that we know about Hyundai Creta, Kia Seltos, Tata Harrier and Mahindra Scorpio-N rival

April 5, 2024 | msn.com

Disease Severity Similar for RSV as Unvaccinated COVID-19, Influenza

April 4, 2024 | msn.com

12 Cheap College Meals People Still Love Long After Graduation

March 22, 2024 | finance.yahoo.com

BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT

March 13, 2024 | msn.com

FJ Cruiser 2.0? Toyota Planning New Rugged SUV for Late 2024

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 12, 2024 | msn.com

11 Signs Eggs Are Not Safe To Eat

March 11, 2024 | msn.com

Toyota said to be working on new SUV based on Hilux Champ, to slot below Fortuner

March 8, 2024 | msn.com

Toyota to introduce Mini-Fortuner to compete with Mahindra Scorpio N: Check features, expected launch timeline

March 6, 2024 | msn.com

Toyota mini-Fortuner global debut this year, likely to be called FJ

March 6, 2024 | finance.yahoo.com

BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order

February 23, 2024 | msn.com

Age of Mythology: Retold's developers are going 'way beyond' the definitive editions for Age of Empires: 'We want to build the game in your head'

February 3, 2024 | msn.com

Asian Cup 2023: Quarter-final fixtures, results, schedule, group tables and how to watch in UK

February 2, 2024 | msn.com

Third-Gen Toyota Fortuner Transforms into a Rugged Off-Road SUV. Possible 4Runner Variant?

February 2, 2024 | msn.com

Third-Gen Toyota Fortuner Morphs Into a Boxy Off-Road SUV. It Could Double as a 4Runner?

January 31, 2024 | tmcnet.com

iHit Tech Wowed the TPE24 Expo as Top1 Choice for Intense Flavor and Silky Vapor

December 20, 2023 | msn.com

How Toyota Was Able to Make Its $13,000 Future Pickup So Affordable

November 13, 2023 | msn.com

Toyota's $10,000 Pickup Of The Future Is Utilitarian Perfection

November 6, 2023 | news.yahoo.com

Toyota’s $10,000 Future Pickup Truck Is Basic Transportation Perfection

October 31, 2023 | msn.com

Toyota’s Future-Ready Pickup Truck: IMV 0 Wows Dads at 2023 Japan Mobility Show

October 27, 2023 | msn.com

Toyota IMV 0 Concept: Everything We Know So Far

October 25, 2023 | msn.com

Toyota FT-3e Concept Gives a Glimpse of the Next-Generation bZ4X

October 25, 2023 | msn.com

2023 Tokyo motor show: latest news and pictures

October 24, 2023 | msn.com

$52M in Tax-Exempt Bond Financing Approved For NY Blood Center HQ

See More Headlines

Receive IMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:IMV
CUSIP: N/A
CIK: N/A
Web: www.imvaccine.com
Phone: +1-902-4921819
Fax: N/A
Employees: 63
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($6.11)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-37,990,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -508.58%
Return on Assets: -61.78%

Debt

Debt-to-Equity Ratio: 1,231.01
Current Ratio: 2.93
Quick Ratio: 2.32

Sales & Book Value

Annual Sales: C$23,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 1.61
Book Value: C($0.69) per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 11,710,000
Free Float: N/A
Market Cap: C$13.12 million
Optionable: Not Optionable
Beta: 1.52

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Andrew Hall M.Sc.
CEO & Director
Ms. Brittany Davison C.A. (Age 33)
CPA, Chief Accounting Officer, Corp. Sec. & Director
Comp: $207.9k
Dr. Jeremy R. Graff Ph.D. (Age 53)
Chief Scientific Officer
Comp: $558.1k
Delphine Davan
Sr. Director of Communications & Investor Relations
Mr. Stephan Fiset M.B.A.
M.Sc., VP of Clinical Research

Key Competitors

View All Competitors

IMV Stock Analysis - Frequently Asked Questions

Should I buy or sell IMV stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IMV in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IMV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMV, but not buy additional shares or sell existing shares.
View IMV analyst ratings or view top-rated stocks.
When did IMV's stock split?: IMV's stock reverse split before market open on Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What other stocks do shareholders of IMV own?: Based on aggregate information from My MarketBeat watchlists, some companies that other IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN), Aphria (APHA), Enbridge (ENB), Sorrento Therapeutics (SRNE), Medical Facilities (DR) and ReNeuron Group (RENE).
How do I buy shares of IMV?: Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:IMV) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

IMV (IMV) Stock Price, News & Analysis

About IMV Stock (TSE:IMV)

IMV Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

IMV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info